288 related articles for article (PubMed ID: 23151073)
1. Vascular factors and mitochondrial dysfunction: a central role in the pathogenesis of Alzheimer's disease.
Orsucci D; Mancuso M; Ienco EC; Simoncini C; Siciliano G; Bonuccelli U
Curr Neurovasc Res; 2013 Feb; 10(1):76-80. PubMed ID: 23151073
[TBL] [Abstract][Full Text] [Related]
2. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer's Disease.
Rai SN; Singh C; Singh A; Singh MP; Singh BK
Mol Neurobiol; 2020 Jul; 57(7):3075-3088. PubMed ID: 32462551
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial links between brain aging and Alzheimer's disease.
Wilkins HM; Swerdlow RH
Transl Neurodegener; 2021 Sep; 10(1):33. PubMed ID: 34465385
[TBL] [Abstract][Full Text] [Related]
6. From mitochondrial dysfunction to amyloid beta formation: novel insights into the pathogenesis of Alzheimer's disease.
Leuner K; Müller WE; Reichert AS
Mol Neurobiol; 2012 Aug; 46(1):186-93. PubMed ID: 22833458
[TBL] [Abstract][Full Text] [Related]
7. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.
Onyango IG; Khan SM
Curr Alzheimer Res; 2006 Sep; 3(4):339-49. PubMed ID: 17017864
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction: the missing link between aging and sporadic Alzheimer's disease.
Grimm A; Friedland K; Eckert A
Biogerontology; 2016 Apr; 17(2):281-96. PubMed ID: 26468143
[TBL] [Abstract][Full Text] [Related]
10. The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects.
Rocchi A; Orsucci D; Tognoni G; Ceravolo R; Siciliano G
Curr Alzheimer Res; 2009 Jun; 6(3):224-37. PubMed ID: 19519304
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
Tyumentsev MA; Stefanova NA; Muraleva NA; Rumyantseva YV; Kiseleva E; Vavilin VA; Kolosova NG
J Alzheimers Dis; 2018; 63(3):1075-1088. PubMed ID: 29710722
[TBL] [Abstract][Full Text] [Related]
12. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease.
Aliev G; Smith MA; Seyidov D; Neal ML; Lamb BT; Nunomura A; Gasimov EK; Vinters HV; Perry G; LaManna JC; Friedland RP
Brain Pathol; 2002 Jan; 12(1):21-35. PubMed ID: 11770899
[TBL] [Abstract][Full Text] [Related]
13. RCAN1 overexpression promotes age-dependent mitochondrial dysregulation related to neurodegeneration in Alzheimer's disease.
Wong H; Levenga J; Cain P; Rothermel B; Klann E; Hoeffer C
Acta Neuropathol; 2015 Dec; 130(6):829-43. PubMed ID: 26497675
[TBL] [Abstract][Full Text] [Related]
14. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.
Swerdlow RH; Khan SM
Med Hypotheses; 2004; 63(1):8-20. PubMed ID: 15193340
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.
Yan MH; Wang X; Zhu X
Free Radic Biol Med; 2013 Sep; 62():90-101. PubMed ID: 23200807
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease.
Aliev G; Priyadarshini M; Reddy VP; Grieg NH; Kaminsky Y; Cacabelos R; Ashraf GM; Jabir NR; Kamal MA; Nikolenko VN; Zamyatnin AA; Benberin VV; Bachurin SO
Curr Med Chem; 2014; 21(19):2208-17. PubMed ID: 24372221
[TBL] [Abstract][Full Text] [Related]
17. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.
Aliev G; Smith MA; Obrenovich ME; de la Torre JC; Perry G
Neurotox Res; 2003; 5(7):491-504. PubMed ID: 14715433
[TBL] [Abstract][Full Text] [Related]
18. Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer's disease: a new approach to therapy.
Sochocka M; Koutsouraki ES; Gasiorowski K; Leszek J
CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):870-81. PubMed ID: 23469836
[TBL] [Abstract][Full Text] [Related]
19. Oxidative stress and altered mitochondrial protein expression in the absence of amyloid-β and tau pathology in iPSC-derived neurons from sporadic Alzheimer's disease patients.
Birnbaum JH; Wanner D; Gietl AF; Saake A; Kündig TM; Hock C; Nitsch RM; Tackenberg C
Stem Cell Res; 2018 Mar; 27():121-130. PubMed ID: 29414602
[TBL] [Abstract][Full Text] [Related]
20. Role of mitochondrial dysfunction in Alzheimer's disease.
Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
